GlassScriptPhysician profile
Sunaina G Sehwani
NPI 1841481439
$6,425.88
in general payments reported to CMS, 2019-2025
57 companies · $993 in 2025
The $993 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,112 · 2020: $691 · 2021: $1,499 · 2022: $949 · 2023: $635 · 2024: $547 · 2025: $993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,174.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,132.85 | 2019-2025 | Lo Loestrin Fe |
| Glaxosmithkline, LLC. | $450.01 | 2021-2023 | Nucala |
| Myovant Sciences INC. | $426.77 | 2021-2022 | |
| Therapeuticsmd, INC. | $357.28 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $346.58 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $334.83 | 2019-2025 | |
| Caldera Medical, INC | $268.74 | 2025 | |
| Sage Therapeutics, LLC | $252.01 | 2022-2025 | Zurzuvae |
| Intuitive Surgical, INC. | $241.20 | 2023-2024 | Da Vinci Surgical System |
| Bard Access Systems, INC. | $193.48 | 2019 | |
| Astellas Pharma US INC | $176.34 | 2019-2024 | Veozah |
| Shield Therapeutics INC | $163.61 | 2023-2025 | Accrufer |
| Novo Nordisk INC | $128.03 | 2021 | |
| Daiichi Sankyo INC. | $114.33 | 2020-2021 | |
| Evofem Biosciences, INC. | $107.83 | 2020-2022 |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunaina Sehwani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.